National Eye Institute; Notice of Closed Meeting, 52976-52977 [2022-18702]

Download as PDF 52976 Federal Register / Vol. 87, No. 167 / Tuesday, August 30, 2022 / Notices or manifestation of the onset or significant aggravation of which did not occur within the time period set forth in the Table but which was caused by a vaccine’’ referred to in the Table. In accordance with Section 2112(b)(2), all interested persons may submit written information relevant to the issues described above in the case of the petitions listed below. Any person choosing to do so should file an original and three (3) copies of the information with the Clerk of the United States Court of Federal Claims at the address listed above (under the heading FOR FURTHER INFORMATION CONTACT), with a copy to HRSA addressed to Director, Division of Injury Compensation Programs, Health Systems Bureau, 5600 Fishers Lane, 08N146B, Rockville, Maryland 20857. The Court’s caption (Petitioner’s Name v. Secretary of HHS) and the docket number assigned to the petition should be used as the caption for the written submission. Chapter 35 of title 44, United States Code, related to paperwork reduction, does not apply to information required for purposes of carrying out the Program. Carole Johnson, Administrator. khammond on DSKJM1Z7X2PROD with NOTICES List of Petitions Filed 1. James Shapouri, Valencia, California, Court of Federal Claims No: 22–0736V 2. Christopher D. Beckner, Salem, Virginia, Court of Federal Claims No: 22–0737V 3. Beatrice Cain, Helotes, Texas, Court of Federal Claims No: 22–0739V 4. Kristin Burger on behalf of S. B., Harrodsburg, Kentucky, Court of Federal Claims No: 22–0740V 5. Rita Martins on behalf of Z. M., Phoenix, Arizona, Court of Federal Claims No: 22– 0742V 6. Douglas Pierce, Dartmouth, Massachusetts, Court of Federal Claims No: 22–0743V 7. Jonathan McWaters on behalf of D. M., Phoenix, Arizona, Court of Federal Claims No: 22–0744V 8. Nadia Baksh, Phoenix, Arizona, Court of Federal Claims No: 22–0746V 9. Susan Demilt, Manahawkin, New Jersey, Court of Federal Claims No: 22–0747V 10. Annalyse Treat, Reading, Pennsylvania, Court of Federal Claims No: 22–0748V 11. Kerry Ann Fletcher, Wilmington, Delaware, Court of Federal Claims No: 22–0752V 12. Megan Hydutsky, Phoenixville, Pennsylvania, Court of Federal Claims No: 22–0753V 13. Jeffrey Struiksma, Tukwila, Washington, Court of Federal Claims No: 22–0754V 14. Michael Smith, Boston, Massachusetts, Court of Federal Claims No: 22–0757V 15. Cole Henshaw, Boston, Massachusetts, Court of Federal Claims No: 22–0758V 16. Jeannie Delacour, Seattle, Washington, Court of Federal Claims No: 22–0759V 17. John Fallstead, Mountain View, California, Court of Federal Claims No: VerDate Sep<11>2014 17:24 Aug 29, 2022 Jkt 256001 22–0760V 18. Charles Tillman, Pittsburgh, Pennsylvania, Court of Federal Claims No: 22–0762V 19. Melissa McCall, Baltimore, Maryland, Court of Federal Claims No: 22–0763V 20. Eliza Welder, Victoria, Texas, Court of Federal Claims No: 22–0764V 21. Sherrie Nguyen on behalf of N. N., Auburn, Washington, Court of Federal Claims No: 22–0765V 22. Debra Powers, Dresher, Pennsylvania, Court of Federal Claims No: 22–0766V 23. Marni Schmidt, New York, New York, Court of Federal Claims No: 22–0772V 24. Steven Santineau and Melinda Santineau on behalf of E. S., Boston, Massachusetts, Court of Federal Claims No: 22–0773V 25. Mary M. Wyckoff, Sacramento, California, Court of Federal Claims No: 22–0774V 26. James Tyree, Seattle, Washington, Court of Federal Claims No: 22–0776V 27. Andrew Eberling, Marlton, New Jersey, Court of Federal Claims No: 22–0778V 28. Tammy Wilcoxon on behalf of A. T., Phoenix, Arizona, Court of Federal Claims No: 22–0779V 29. Melanie Fata, Peoria, Illinois, Court of Federal Claims No: 22–0781V 30. Valerie Allen on behalf of K. A., Phoenix, Arizona, Court of Federal Claims No: 22– 0783V 31. Janelle Hill, Madison, Wisconsin, Court of Federal Claims No: 22–0785V 32. Brian Bugge, New York, New York, Court of Federal Claims No: 22–0786V 33. David Mosher, Portland, Maine, Court of Federal Claims No: 22–0788V 34. Jennifer Nolte on behalf of C. W., Phoenix, Arizona, Court of Federal Claims No: 22–0789V 35. Leroy Alston, Boston, Massachusetts, Court of Federal Claims No: 22–0790V 36. Carole Hillard, West Reading, Pennsylvania, Court of Federal Claims No: 22–0791V 37. Marco DeLeon, Anaheim, California, Court of Federal Claims No: 22–0792V 38. Craig Mendenhall, Greenville, Ohio, Court of Federal Claims No: 22–0793V 39. Lesley Koski, Hancock, Michigan, Court of Federal Claims No: 22–0794V 40. Warren Erbsen, Denver, Colorado, Court of Federal Claims No: 22–0795V 41. Gerry Scott, Overland Park, Kansas, Court of Federal Claims No: 22–0796V 42. Allison Conine, Boston, Massachusetts, Court of Federal Claims No: 22–0799V 43. Daniel Lefkowitz, New York, New York, Court of Federal Claims No: 22–0801V 44. Tammy Zollman, Phoenix, Arizona, Court of Federal Claims No: 22–0802V 45. Braelyn Caton Cates, Phoenix, Arizona, Court of Federal Claims No: 22–0803V 46. Mark Hernandez, York, Pennsylvania, Court of Federal Claims No: 22–0805V 47. Meliss Langert, Fairfax, Virginia, Court of Federal Claims No: 22–0809V 48. Katherine Nottenburg, New York City, New York, Court of Federal Claims No: 22–0810V 49. Humberto Donato-Brugueras, San Juan, Puerto Rico, Court of Federal Claims No: 22–0812V 50. Herminio L. Irizarry, Miami, Florida, Court of Federal Claims No: 22–0813V PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 51. Jerry Roberts, Hodges, South Carolina, Court of Federal Claims No: 22–0817V 52. Scott Chovanec, Boston, Massachusetts, Court of Federal Claims No: 22–0818V 53. Jaclyn Vanacore, New Fairfield, Connecticut, Court of Federal Claims No: 22–0819V 54. Joseph Schmucker, Warner Robins, Georgia, Court of Federal Claims No: 22– 0822V 55. Patti Paez, Hoffman Estates, Illinois, Court of Federal Claims No: 22–0823V 56. Jonathan Simpson, New York, New York, Court of Federal Claims No: 22–0825V 57. Phillip R. Sims, Boca Raton, Florida, Court of Federal Claims No: 22–0826V 58. Benjamin Gootee, New Orleans, Louisiana, Court of Federal Claims No: 22–0827V 59. John Marlowe and Pasha Marlowe on behalf of J. M., Phoenix, Arizona, Court of Federal Claims No: 22–0829V 60. Osmyn Lavor Deuel, St. George, Utah, Court of Federal Claims No: 22–0830V 61. Steven Mills on behalf of Barbara Mills, Deceased, San Mateo, California, Court of Federal Claims No: 22–0831V [FR Doc. 2022–18632 Filed 8–29–22; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; NEI Individual Training Grant K99 Applications. Date: October 6, 2022. Time: 8:30 a.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Eye Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 3400, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Jeanette M Hosseini, Ph.D., Scientific Review Officer, 6700B Rockledge Drive, Suite 3400, Bethesda, MD 20892, (301) 451–2020, jeanetteh@mail.nih.gov. E:\FR\FM\30AUN1.SGM 30AUN1 Federal Register / Vol. 87, No. 167 / Tuesday, August 30, 2022 / Notices (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS) Dated: August 25, 2022. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–18702 Filed 8–29–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings khammond on DSKJM1Z7X2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Cardiovascular and Respiratory Sciences Integrated Review Group; Lung Cellular, Molecular, and Immunobiology Study Section. Date: September 26–27, 2022. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: George M Barnas, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD 20892, 301–435– 0696, barnasg@csr.nih.gov. Name of Committee: Integrative, Functional and Cognitive Neuroscience Integrated Review Group; Neuroscience of Basic Visual Processes Study Section. Date: September 29, 2022. Time: 8:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301–435– 1242, kgt@mail.nih.gov. Name of Committee: Healthcare Delivery and Methodologies Integrated Review Group; VerDate Sep<11>2014 17:24 Aug 29, 2022 Jkt 256001 Interdisciplinary Clinical Care in Specialty Care Settings Study Section. Date: September 29–30, 2022. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Washington DC/Vermont Ave. 1199 Vermont Avenue NW, Washington, DC 20005. Contact Person: Abu Saleh Mohammad Abdullah, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827–4043, abuabdullah.abdullah@nih.gov. Name of Committee: Healthcare Delivery and Methodologies Integrated Review Group; Health Services: Quality and Effectiveness Study Section. Date: September 29–30, 2022. Time: 9:00 a.m. to 9:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Angela Denise Thrasher, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1000J, Bethesda, MD 20892, (301) 480–6894, thrasherad@csr.nih.gov. Name of Committee: Digestive, Kidney and Urological Systems Integrated Review Group; Kidney and Urological Systems Function and Dysfunction Study Section. Date: October 13–14, 2022. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD 20852. Contact Person: Santanu Banerjee, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2106, Bethesda, MD 20892, (301) 435–5947, banerjees5@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel Cancer Nanotechnology. Date: October 13–14, 2022. Time: 9:30 a.m. to 8:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Raj K Krishnaraju, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6190, Bethesda, MD 20892, 301–435–1047, kkrishna@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) PO 00000 Frm 00077 Fmt 4703 Sfmt 9990 52977 Dated: August 25, 2022. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–18704 Filed 8–29–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; NEI Clinical Trial Network Review. Date: September 19, 2022. Time: 10:00 a.m. to 12:15 p.m. Agenda: To review and evaluate grant applications. Place: National Eye Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 3400, Rockville, MD 20892 (Virtual Meeting). Contact Person: Brian Hoshaw, Ph.D., Chief, Scientific Review Branch, National Eye Institute, National Institutes of Health, Division of Extramural Research, 6700B Rockledge Drive, Suite 3400, Rockville, MD 20892, (301) 451–2020, hoshawb@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS) Dated: August 19, 2022. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–18703 Filed 8–29–22; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\30AUN1.SGM 30AUN1

Agencies

[Federal Register Volume 87, Number 167 (Tuesday, August 30, 2022)]
[Notices]
[Pages 52976-52977]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18702]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Eye Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Eye Institute Special Emphasis 
Panel; NEI Individual Training Grant K99 Applications.
    Date: October 6, 2022.
    Time: 8:30 a.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Eye Institute, National Institutes of Health, 
6700B Rockledge Drive, Suite 3400, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Jeanette M Hosseini, Ph.D., Scientific Review 
Officer, 6700B Rockledge Drive, Suite 3400, Bethesda, MD 20892, 
(301) 451-2020, [email protected].


[[Page 52977]]


(Catalogue of Federal Domestic Assistance Program Nos. 93.867, 
Vision Research, National Institutes of Health, HHS)

    Dated: August 25, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-18702 Filed 8-29-22; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.